| Age (year) | Gender | Diagnosis | Tumor location | Enneking staging [41] | Neo-adjuvant chemotherapy | Follow-up (month) | Oncologic outcome | Complications | MSTS-93 score | Knee ROM (°) |
---|---|---|---|---|---|---|---|---|---|---|---|
Patient | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
  1 | 27 | F | Ewing sarcoma | Femur, D | IIB | Two circles | 42 | NED | PPF | 30 | 140 |
  2 | 61 | M | Chondrosarcoma | Femur, P | IIB | No | 39 | NED |  | 25 | 110 |
  3 | 50 | M | Chondrosarcoma | Femur, P | IIB | No | 50 | NED |  | 24 | 100 |
  4 | 11 | F | Osteosarcoma | Femur, D | IIB | Two circles | 48 | NED |  | 27 | 130 |
  5 | 57 | F | MLC | Femur, D | NA | No | 36 | AWD |  | 27 | 120 |
  6 | 30 | F | Osteosarcoma | Femur, P | IIB | Two circles | 43 | NED |  | 24 | 120 |
  7 | 14 | M | Osteosarcoma | Femur, P | IIB | Two circles | 45 | NED |  | 25 | 110 |
  8 | 45 | M | POS | Femur, D | IIB | No | 40 | NED |  | 28 | 120 |
  9 | 13 | M | Osteosarcoma | Tibia, D | IIB | Two circles | 41 | NED | PPF+EAL | 29 | 120 |
  10 | 19 | F | Ewing sarcoma | Tibia, D | IIB | Two circles | 34 | NED |  | 30 | 140 |
  11 | 22 | F | Osteosarcoma | Tibia, D | IIB | Two circles | 54 | NED |  | 23 | 110 |
  12 | 38 | F | Osteosarcoma | Tibia, D | IIB | Two circles | 48 | NED |  | 28 | 130 |
  13 | 16 | F | Osteosarcoma | Tibia, D | IIB | Two circles | 37 | NED |  | 26 | 120 |
  14 | 12 | M | Ewing sarcoma | Tibia, D | IIB | Two circles | 43 | NED |  | 26 | 120 |
  15 | 15 | F | Osteosarcoma | Tibia, D | IIB | Two circles | 42 | NED |  | 25 | 110 |
Median | 22 | Â | Â | Â | Â | Â | 42 | Â | Â | 26 | 120 |